Medicare Enrolled
Dr. Ravi Rao, MD
Hematology & Oncology · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rao
Dr. Ravi Rao is a hematology & oncology specialist in Fresno, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 547,778 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rao received a total of $85,554 from 53 pharmaceutical and/or device companies across 318 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in CA
$85,554 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗547,778
Medicare services
Top 0% in CA for hematology & oncology
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
168,750 | $1 | $9 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
119,300 | $2 | $12 |
| Nivolumab injection (Opdivo) | 49,480 | $24 | $72 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
18,180 | $38 | $110 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
17,725 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 17,160 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 14,690 | $1 | $11 |
| Pembrolizumab injection (Keytruda) | 13,400 | $43 | $127 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
12,812 | $0 | $8 |
| Paclitaxel chemotherapy injection | 11,194 | $0 | $8 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
10,164 | $26 | $88 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
8,500 | $0 | $9 |
| Injection, granisetron, extended-release, 0.1 mg | 7,200 | $5 | $20 |
| Lanreotide injection, 1 mg A 1 mg injection of lanreotide medication administered into the body. |
7,200 | $45 | $172 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
6,050 | $36 | $118 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
4,764 | $8 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
4,662 | $8 | $11 |
| Bevacizumab-maly biosimilar injection, 10 mg An injection of bevacizumab-maly, a biosimilar medication, with a dosage of 10 mg. |
4,360 | $57 | $185 |
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
4,200 | $0 | $8 |
| Injection, durvalumab, 10 mg | 3,874 | $62 | $193 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
3,815 | $4 | $112 |
| Iron infusion (Monoferric) | 3,600 | $17 | $61 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,429 | $0 | $8 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
3,419 | $10 | $27 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,260 | $33 | $225 |
| Iron level test | 1,930 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
1,930 | $9 | $22 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
1,892 | $13 | $35 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,822 | $98 | $418 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,670 | $1 | $10 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
1,460 | $20 | $64 |
| Rituximab-arrx biosimilar injection, 10 mg An injection of rituximab-arrx, a biosimilar medication, administered in a 10 mg dose. |
1,400 | $35 | $185 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
1,227 | $6 | $16 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,095 | $11 | $40 |
| Injection, leucovorin calcium, per 50 mg | 888 | $3 | $13 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
728 | $2 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
714 | $141 | $558 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
689 | $110 | $400 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
646 | $24 | $87 |
| Leuprolide injectable, camcevi, 1 mg | 462 | $68 | $222 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
449 | $4 | $10 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
426 | $2 | $12 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 423 | $283 | $898 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
399 | $52 | $197 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
398 | $1,353 | $4,921 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
351 | $70 | $286 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
322 | $1 | $2 |
| Pegfilgrastim-fpgk biosimilar injection, 0.5 mg An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg. |
312 | $274 | $853 |
| PSA test (prostate cancer screening) | 290 | $18 | $46 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
276 | $3 | $9 |
| Electrophoresis laboratory test A laboratory testing technique that separates molecules based on their size and electrical charge. |
272 | $60 | $154 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 268 | $3 | $14 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
265 | $61 | $222 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
265 | $55 | $194 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
239 | $1 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
214 | $13 | $47 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
203 | $16 | $43 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
202 | $4 | $11 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
195 | $23 | $84 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
188 | $19 | $48 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
171 | $95 | $252 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
166 | $1 | $10 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
154 | $16 | $42 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
147 | $9 | $24 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
140 | $15 | $38 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
140 | $17 | $61 |
| New patient office visit, complex (60-74 min) | 133 | $159 | $594 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
128 | $255 | $943 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
123 | $50 | $145 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
120 | $4 | $11 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 113 | $20 | $53 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
103 | $12 | $32 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
102 | $9 | $23 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 98 | $132 | $502 |
| Injection, alteplase recombinant, 1 mg | 94 | $67 | $220 |
| CA 19-9 tumor antigen test A blood test that measures the level of CA 19-9, a substance that can be found in the blood of some people with cancer. This quantitative analysis detects and measures the specific tumor antigen. |
93 | $20 | $53 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 87 | $20 | $53 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
75 | $27 | $90 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
65 | $4 | $12 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
63 | $62 | $193 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
62 | $14 | $37 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
60 | $110 | $410 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
57 | $107 | $628 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
56 | $47 | $171 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
54 | $28 | $94 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
54 | $4 | $14 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
51 | $1,363 | $4,921 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
48 | $17 | $58 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
42 | $3,535 | $9,900 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
38 | $16 | $41 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $140 | $521 |
| Coagulation assessment blood test A blood test that measures how long it takes for blood to clot. The sample can be plasma or whole blood. |
35 | $6 | $16 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
31 | $152 | $639 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
28 | $95 | $480 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
26 | $8 | $22 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
19 | $148 | $479 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
19 | $53 | $248 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
18 | $29 | $74 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
15 | $71 | $153 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
15 | $32 | $307 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
33.4% high complexity
61.3% medium
5.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$85,554
Total received (2018-2024)
Avg $12,222/year across 7 years
Top 9% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
318
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,121
2023
$3,458
2022
$3,093
2021
$7,515
2020
$68,362
2019
$1,398
2018
$608
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$160
Celgene Corporation
$160
Novartis Pharmaceuticals Corporation
$101
ABBVIE INC.
$96
GlaxoSmithKline, LLC.
$95
Dendreon Pharmaceuticals LLC
$80
Myriad Genetic Laboratories, Inc.
$73
Exelixis Inc.
$63
PFIZER INC.
$58
Lilly USA, LLC
$54
SpringWorks Therapeutics, Inc.
$50
ARRAY BIOPHARMA INC
$34
Daiichi Sankyo Inc.
$28
Sirtex Medical Inc
$20
Takeda Pharmaceuticals U.S.A., Inc.
$18
BeiGene USA, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
Daiichi Sankyo Inc.
$56,166
AstraZeneca Pharmaceuticals LP
$8,805
Bayer HealthCare Pharmaceuticals Inc.
$6,905
Karyopharm Therapeutics Inc.
$3,021
ADC Therapeutics America, Inc.
$2,400
Cornerstone Specialty Network LLC
$2,000
E.R. Squibb & Sons, L.L.C.
$749
Celgene Corporation
$691
GlaxoSmithKline, LLC.
$551
Sirtex Medical Inc
$474
Novartis Pharmaceuticals Corporation
$402
Pharmacyclics LLC, An AbbVie Company
$233
Myriad Genetic Laboratories, Inc.
$193
Kite Pharma, Inc.
$187
Octapharma USA, Inc.
$187
Astellas Pharma US Inc
$175
Alexion Pharmaceuticals, Inc.
$150
Boston Scientific Corporation
$149
Exelixis Inc.
$144
Shire North American Group Inc
$135
Cardinal Health 108, LLC
$132
Novo Nordisk Inc
$125
GENZYME CORPORATION
$122
Amgen Inc.
$118
Baxter Healthcare
$108
Janssen Biotech, Inc.
$100
ABBVIE INC.
$96
PFIZER INC.
$94
Gilead Sciences, Inc.
$87
Dendreon Pharmaceuticals LLC
$80
Myovant Sciences Inc.
$72
Pharmacyclics LLC, an AbbVie Company
$70
Lilly USA, LLC
$68
Genentech USA, Inc.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$51
SpringWorks Therapeutics, Inc.
$50
BeiGene USA, Inc.
$44
Ipsen Biopharmaceuticals, Inc
$42
TerSera Therapeutics LLC
$42
ARRAY BIOPHARMA INC
$34
EMD Serono, Inc.
$23
Medtronic, Inc.
$23
PharmaEssentia USA Corporation
$22
Agios Pharmaceuticals, Inc.
$21
Dova Pharmaceuticals
$21
Olympus America Inc.
$20
G1 Therapeutics, Inc.
$20
Merck Sharp & Dohme Corporation
$16
Acrotech Biopharma LLC
$16
Deciphera Pharmaceuticals Inc.
$14
Merck Sharp & Dohme LLC
$14
Kyowa Kirin, Inc.
$14
TESARO, Inc.
$12
Top 3 companies account for 84.0% of all-time payments
Associated products mentioned in payments ›
ADVATE · ALUNBRIG · Adempas · Aranesp · Azure · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · COSELA · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENTRESTO · EPKINLY · ERLEADA · EVIS EXERA · Enhertu · FIBRYGA · Fabhalta · GAZYVA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · Imbruvica · JEMPERLI · KEYTRUDA · LORBRENA · LUTATHERA · LYNPARZA · MEKINIST · MYRISK · NUWIQ · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PLUVICTO · POTELIGEO · PROVENGE · PYRUKYND · Perjeta · Pomalyst · QINLOCK · REBLOZYL · SCEMBLIX · SIR-Spheres Microspheres · Soliris · Stivarga · TAGRISSO · TALZENNA · TASIGNA · Tazverik · Trodelvy · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Vitrakvi · WATCHMAN Access System · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XPOVIO · Xofigo · YERVOY · Yescarta · ZEJULA · myChoice CDx
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
28
County median income
$71,434
Nearest hospital to ZIP centroid (approximate)
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rao is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rao experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Rao performed 168,750 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $85,554 from 53 companies across 318 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other hematology & oncology specialists in Fresno?
Dr. Rao's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fresno
Browse hematology & oncology specialists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology